Lv1
18 积分 2021-05-31 加入
Neurofibromatosis type 1: New developments in genetics and treatment
2天前
已完结
FDA Approval Summary: Selumetinib for Plexiform Neurofibroma
16天前
已完结
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial
24天前
已完结
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer
24天前
已完结
Efficacy and Safety of Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1–Associated Plexiform Neurofibromas: Phase IIa Trial and Biomarker Research
26天前
已完结
Epigenetic evolution of isocitrate dehydrogenase-wildtype glioblastomas
3个月前
已完结
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
4个月前
已完结
Targeting the MET pathway for potential treatment of NSCLC
5个月前
已完结
MET amplification increases the metastatic spread of EGFR-mutated NSCLC
8个月前
已完结
皖公网安备34019202002308
